Results 201 to 210 of about 2,682 (215)

Risks Associated with SGLT2 Inhibitors: An Overview

Current Drug Safety, 2018
Anoop Kumar
exaly  

Method for determining sensitivity to SGLT2 inhibitor and sensitivity marker for SGLT2 inhibitor

2020
TAKAYAMA TADATERU, USUI MASAHIRO, KUDO KEIKO   +2 more
openaire   +2 more sources

SGLT2 inhibitors and cardiovascular outcomes

Drug and Therapeutics Bulletin, 2017
openaire   +2 more sources

Dapagliflozin, an SGLT2 inhibitor, for diabetes

The Lancet, 2010
Markolf, Hanefeld, Thomas, Forst
openaire   +2 more sources

Use of SGLT2 inhibitors for diabetes and risk of infection: Analysis using general practice records from the NPS MedicineWise MedicineInsight program

Diabetes Research and Clinical Practice, 2017
Nicole Pratt, Elizabeth Roughead, Světla Gadzhanova   +2 more
exaly  

SGLT2 inhibitors: are they safe?

Postgraduate Medicine, 2018
Theodosios Filippatos, Moses Elisaf
exaly  

The expanding résumé of SGLT2 inhibitors

The Lancet Diabetes & Endocrinology, 2019
openaire   +2 more sources

SGLT2 inhibitors-induced electrolyte abnormalities: An analysis of the associated mechanisms

Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2018
Theodosios Filippatos, Moses Elisaf, George Liamis   +2 more
exaly  

SGLT2 Inhibitors and Iron

JACC: Heart Failure, 2023
openaire   +1 more source

The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors

JACC: CardioOncology
Anne Blaes, Beshay Zordoky, Mina Y George   +2 more
exaly